BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12946661)

  • 1. CD4+ T, but not CD8+ or B, lymphocytes mediate facial motoneuron survival after facial nerve transection.
    Serpe CJ; Coers S; Sanders VM; Jones KJ
    Brain Behav Immun; 2003 Oct; 17(5):393-402. PubMed ID: 12946661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural killer cells do not mediate facial motoneuron survival after facial nerve transection.
    Byram SC; Serpe CJ; Pruett SB; Sanders VM; Jones KJ
    Brain Behav Immun; 2003 Dec; 17(6):417-25. PubMed ID: 14583233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain-derived neurotrophic factor supports facial motoneuron survival after facial nerve transection in immunodeficient mice.
    Serpe CJ; Byram SC; Sanders VM; Jones KJ
    Brain Behav Immun; 2005 Mar; 19(2):173-80. PubMed ID: 15664790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune-mediated neuroprotection of axotomized mouse facial motoneurons is dependent on the IL-4/STAT6 signaling pathway in CD4(+) T cells.
    Deboy CA; Xin J; Byram SC; Serpe CJ; Sanders VM; Jones KJ
    Exp Neurol; 2006 Sep; 201(1):212-24. PubMed ID: 16806176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4(+) T cell-mediated facial motoneuron survival after injury: Distribution pattern of cell death and rescue throughout the extent of the facial motor nucleus.
    Canh MY; Serpe CJ; Sanders V; Jones KJ
    J Neuroimmunol; 2006 Dec; 181(1-2):93-9. PubMed ID: 17045343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of facial motoneuron loss following facial nerve transection in severe combined immunodeficient mice.
    Serpe CJ; Sanders VM; Jones KJ
    J Neurosci Res; 2000 Oct; 62(2):273-8. PubMed ID: 11020219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional recovery and facial motoneuron survival are influenced by immunodeficiency in crush-axotomized mice.
    Beahrs T; Tanzer L; Sanders VM; Jones KJ
    Exp Neurol; 2010 Jan; 221(1):225-30. PubMed ID: 19913014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of peripheral immune status on central molecular responses to facial nerve axotomy.
    Setter DO; Runge EM; Schartz ND; Kennedy FM; Brown BL; McMillan KP; Miller WM; Shah KM; Haulcomb MM; Sanders VM; Jones KJ
    Brain Behav Immun; 2018 Feb; 68():98-110. PubMed ID: 29030217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exacerbation of facial motoneuron loss after facial nerve transection in severe combined immunodeficient (scid) mice.
    Serpe CJ; Kohm AP; Huppenbauer CB; Sanders VM; Jones KJ
    J Neurosci; 1999 Jun; 19(11):RC7. PubMed ID: 10341268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune cell-mediated neuroprotection is independent of estrogen action through estrogen receptor-alpha.
    Xin J; Fargo KN; Tanzer L; Sanders VM; Jones KJ
    Metab Brain Dis; 2012 Mar; 27(1):23-8. PubMed ID: 21975535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotype of CD4+ T cell subsets that develop following mouse facial nerve axotomy.
    Xin J; Wainwright DA; Serpe CJ; Sanders VM; Jones KJ
    Brain Behav Immun; 2008 May; 22(4):528-37. PubMed ID: 18024079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-2 gene knockout affects T lymphocyte trafficking and the microglial response to regenerating facial motor neurons.
    Petitto JM; Huang Z; Lo J; Streit WJ
    J Neuroimmunol; 2003 Jan; 134(1-2):95-103. PubMed ID: 12507776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of facial nerve axotomy on Th2- and Th1-associated chemokine expression in the facial motor nucleus of wild-type and presymptomatic mSOD1 mice.
    Wainwright DA; Xin J; Mesnard NA; Politis CM; Sanders VM; Jones KJ
    J Neuroimmunol; 2009 Nov; 216(1-2):66-75. PubMed ID: 19818514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunodeficiency impairs re-injury induced reversal of neuronal atrophy: relation to T cell subsets and microglia.
    Ha GK; Huang Z; Parikh R; Pastrana M; Petitto JM
    Exp Neurol; 2007 Nov; 208(1):92-9. PubMed ID: 17761165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-15 and IL-15R alpha gene deletion: effects on T lymphocyte trafficking and the microglial and neuronal responses to facial nerve axotomy.
    Huang Z; Ha GK; Petitto JM
    Neurosci Lett; 2007 May; 417(2):160-4. PubMed ID: 17418948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the immune system in the maintenance of mouse facial motoneuron viability after nerve injury.
    Jones KJ; Serpe CJ; Byram SC; Deboy CA; Sanders VM
    Brain Behav Immun; 2005 Jan; 19(1):12-9. PubMed ID: 15581733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOD1(G93A) transgenic mouse CD4(+) T cells mediate neuroprotection after facial nerve axotomy when removed from a suppressive peripheral microenvironment.
    Mesnard-Hoaglin NA; Xin J; Haulcomb MM; Batka RJ; Sanders VM; Jones KJ
    Brain Behav Immun; 2014 Aug; 40():55-60. PubMed ID: 24911596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+ T cell expression of the IL-10 receptor is necessary for facial motoneuron survival after axotomy.
    Runge EM; Iyer AK; Setter DO; Kennedy FM; Sanders VM; Jones KJ
    J Neuroinflammation; 2020 Apr; 17(1):121. PubMed ID: 32303238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4+CD25+ regulatory T cells and CD1-restricted NKT cells do not mediate facial motoneuron survival after axotomy.
    DeBoy CA; Byram SC; Serpe CJ; Wisuri D; Sanders VM; Jones KJ
    J Neuroimmunol; 2006 Jul; 176(1-2):34-8. PubMed ID: 16766044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of immunity in recovery from a peripheral nerve injury.
    Sanders VM; Jones KJ
    J Neuroimmune Pharmacol; 2006 Mar; 1(1):11-9. PubMed ID: 18040787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.